Prof. Thomas F. Luescher

Thomas F. Lüscher

Clinical researcher
Royal Brompton Hospital and Imperial College - London, United Kingdom

Prof. Thomas F. Lüscher is a Professor and Chairman of Cardiology at the University Hospital Zurich and Director of CardioVascular Research at the Institute of Physiology of the University of Zurich, Switzerland. He is Editor-in-chief of the European Heart Journal and he has published hundreds of original research articles and review articles. He is a board certified internist and cardiologist with training in internal medicine at the University Hospital Zurich, cardiovascular physiology and cardiology at the Mayo Clinic, Rochester, Minn., USA and in cardiology and clinical pharmacology at the University Hospital Basel, Switzerland. Prior to this, he was Professor of Pharmacotherapy at the University of Basel, then Professor and vice-chairman of cardiology at the Inselspital of the University of Berne, Switzerland.

Declaration of interest

FunctionCompany
Grants/research supportMedtronic

Latest contributions

Will the SPYRAL-ON Medication Study change my clinical practice?

24 May 2018 – From EuroPCR 2018

Consult this session on "Will the SPYRAL-ON Medication Study change my clinical practice?" if you are interested in renal denervation.

Renal artery denervation in hypertension - Update in 2018

24 May 2018 – From EuroPCR 2018

The year in intervention: essential publications from the EuroIntervention Journal and the European Heart Journal

23 May 2018 – From EuroPCR 2018

Bioresorbable scaffold thrombosis: what have we learnt?

16 May 2017 – From EuroPCR 2017

Consult this session about what have we learnt about bioresorbable scaffold thrombosis presented by D. Capodanno, M. Joner, T. F. Lüscher, Y. Onuma, P. Serruys and N. West. Review incidence and predictors of bioresorbable scaffold thrombosis and gain insights about the mechanism underlying scaffold thrombosis and ongoing treatment.

Critical appraisal of devices for the management of hypertension

18 May 2016 – From EuroPCR 2016

Dr. Felix Mahfoud

Chairperson

Felix Mahfoud
Prof. Thomas F. Luescher

Chairperson

Thomas F. Lüscher

Renal and peripheral interventions

17 May 2016 – From EuroPCR 2016

Prof. Thomas F. Luescher

Chairperson

Thomas F. Lüscher
Dr. Felix Mahfoud

Chairperson

Felix Mahfoud

Theme 2: heart failure interventions

16 May 2016 – From EuroPCR 2016

Antoine Papiernik

Chairperson

Antoine Papiernik
Alexander Schmitz

Chairperson

Alexander Schmitz

Alternatives to catheter-based renal sympathetic denervation in hypertension

21 May 2015 – From EuroPCR 2015

Prof. Thomas F. Luescher

Chairperson

Thomas F. Lüscher

Interventional hypertension treatment - Moving forward

20 May 2015 – From EuroPCR 2015

The year in intervention: essential publications from EuroIntervention Journal and the European Heart Journal

20 May 2015 – From EuroPCR 2015

Chairperson

Paul Cummins
Prof. Pim De Feyter

Chairperson

Pim De Feyter
Prof. Thomas F. Luescher

Chairperson

Thomas F. Lüscher
Prof. Patrick W. Serruys

Chairperson

Patrick W. Serruys

How could fully bioresorbable vascular scaffolds improve PCI outcomes?

20 May 2015 – From EuroPCR 2015

Prof. Patrick W. Serruys

Chairperson

Patrick W. Serruys

SYMPLICITY HTN-3: what should be the impact on clinical practice?

23 May 2014 – From EuroPCR 2014

Prof. Thomas F. Luescher

Chairperson

Thomas F. Lüscher
Dr. Felix Mahfoud

Chairperson

Felix Mahfoud

Renal arterial integrity after sympathetic denervation

23 May 2014 – From EuroPCR 2014

Chairperson

Joost Daemen
Prof. Adam Witkowski

Chairperson

Adam Witkowski

Renal denervation and the Vessix global clinical programme - Current learning leading to future horizons

22 May 2014 – From EuroPCR 2014

Prof. Thomas F. Luescher

Chairperson

Thomas F. Lüscher
Dr. Felix Mahfoud

Chairperson

Felix Mahfoud

Tips and tricks for a successful catheter-based renal sympathetic denervation in difficult anatomies

20 May 2014 – From EuroPCR 2014

New approaches beyond renal denervation to modulate autonomic tone in cardiovascular diseases

20 May 2014 – From EuroPCR 2014

Chairperson

Michael Böhm
Faisal Sharif

Chairperson

Faisal Sharif

EuroIntervention / European Heart Journal@EuroPCR

23 May 2013 – From EuroPCR 2013

Prof. Patrick W. Serruys

Chairperson

Patrick W. Serruys
Prof. Thomas F. Luescher

Chairperson

Thomas F. Lüscher

Chairperson

Ulf Landmesser
Dr. Nico Bruining

Chairperson

Nico Bruining

Chairperson

Paul Cummins

Clinical update on EnligHTN, the original multi-electrode catheter-based renal sympathetic denervation system

23 May 2013 – From EuroPCR 2013

Prof. Thomas F. Luescher

Chairperson

Thomas F. Lüscher

Chairperson

Michael Böhm

Catheter-based renal sympathetic denervation – Building momentum with the next generation Vessix system

22 May 2013 – From EuroPCR 2013

Dr. Felix Mahfoud

Chairperson

Felix Mahfoud
Prof. Thomas F. Luescher

Chairperson

Thomas F. Lüscher